SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-20-038999
Filing Date
2020-08-10
Accepted
2020-08-10 17:14:47
Documents
5
Effectiveness Date
2020-08-10

Document Format Files

Seq Description Document Type Size
1 S-8 sbph-s8.htm S-8 120409
2 EX-5.1 sbph-ex51_7.htm EX-5.1 14038
3 EX-23.1 sbph-ex231_6.htm EX-23.1 2827
4 GRAPHIC gmrjpsgq4sv3000002.jpg GRAPHIC 8006
5 GRAPHIC gmrjpsgq4sv3000001.jpg GRAPHIC 10797
  Complete submission text file 0001564590-20-038999.txt   164489
Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-243754 | Film No.: 201090295
SIC: 2834 Pharmaceutical Preparations